The important role of emotion regulation and expression in adaptation to breast cancer is now widely recognized. Studies have shown that optimal emotion regulation strategies, including less constrained emotional expression, are associated with better adaptation. Our objective was to systematically review measures used to assess the way women with breast cancer regulate their emotions. This systematic review was conducted in accordance with PRISMA guidelines. Nine different databases were searched. Data were independently extracted and assessed by two researchers. English-language articles that have used at least one instrument to measure strategies to regulate emotions in women with breast cancer were included. Of 679 abstracts 2 identified 59 studies were deemed eligible for inclusion. Studies were coded regarding their objectives, methods, and results. We identified 16 instruments used to measure strategies of emotion regulation and expression. The most frequently employed instrument was the Courtauld Emotional Control Scale. Few psychometric proprieties other than internal consistency were reported for most instruments. Many studies did not include important information regarding descriptive characteristics and psychometric proprieties of the instruments used. The instruments used tap different aspects of emotion regulation. Specific instruments should be explored further with regard to content, validity, and reliability in the context of breast cancer.
Introduction
In the context of breast cancer, the regulation of emotion, especially emotional expression, has been linked to patients' adaptation and well-being. The diagnosis and treatment of breast cancer are stressful experiences that can evoke a variety of negative emotions and broader affective experiences such as anxiety, sadness, anger, guilt, and fear of death and suffering (Adler & Page, 2008) . It is now widely recognized that the way women regulate and express their emotions can influence not only their psychological adaptation but also their endocrine and immune functioning, which play a role in patients' quality of life and cancer prognosis (Austenfeld & Stanton, 2004; Giese-Davis & Spiegel, 2003; Giese-Davis, DiMiceli, Sephton, & Spiegel, 2006; Gross, 1989; Watson, Greer, & Rowden, 1991) . More specifically, women with breast cancer who reported using generally less adaptive strategies to regulate or express their emotions (e.g., suppression or inhibition) also reported more emotional distress, depressive symptoms, anxiety, and lower quality of life and physical health (Classen et al., 1996; Lieberman & Goldstein, 2006; Low et al., 2006; Wang et al., 2014) . There is also evidence that repressive emotional styles are linked to physiological difficulties such as problematic cortisol regulation and higher blood pressure (Giese-Davis et al., 2004; .
A wide range of self-report measures have been developed to assess emotion regulation and related constructs (e.g., the Emotion Regulation Questionnaire; the Cognitive Emotion Regulation Questionnaire; the Emotional Expressivity Scale). However, decisions about which measure to use are challenging given the diverse conceptualizations and elements of emotion regulation. The lack of agreement among experts regarding the definition and conceptualization of emotion regulation has led to the development of a large number and variety of measures to assess this construct. While each measure may be identified as assessing aspects of emotion regulation, they emphasize different constructs depending on the authors' conceptualization of emotion regulation and its key components. For instance, some experts argue that one's ability to identify emotions is a key feature of emotion regulation (e.g., Gratz & Roemer, 2004; Taylor, 1994) . Others focus on one's tendency to directly engage with and express negative emotions as key elements of emotion regulation (e.g., Gross & John, 2003; Watson & Greer, 1983) .
A process-oriented view of emotion regulation has begun to dominate the field that emphasizes multiple kinds of regulatory strategies. Thompson (1994) defined emotion regulation as "the extrinsic and intrinsic processes responsible for monitoring, evaluating, and modifying emotional reactions, especially their intensive and temporal features, to accomplish one's goals" (p. 27-28) . Gross (1998) , like Thompson, focuses on emotion regulation as a process in his influential work. He defines emotion regulation as "the process by which individuals influence 4 which emotions they have, when they have them, and how they experience and express these emotions" (p. 275). Campos, Frankel, and Camras (2004) offer a complementary view, defining emotion regulation as "the modification of any process in the system that generates emotion or its manifestation in behavior" (p. 380). For the purposes of this review, it is notable that each of these process definitions highlights the modulation of emotional expression as a key component of emotion regulation.
Although emotion regulation and coping are considered closely related constructs (Schulz & Lazarus, 2012) , theorists have also noted differences in these constructs. Compas et al. (2013) note that both coping and emotion regulation are self-regulatory processes that include controlled and purposeful efforts that can change over time. Coping can include efforts to regulate emotion when an individual is under stress. In terms of important differences, Compas et al. (2013) emphasized the fact that emotion regulation is commonly understood to include conscious and unconscious processes while coping has more commonly included only controlled responses.
More generally, coping refers to responses to stress while emotion regulation involves regulatory efforts engaged in a wider range of situations and affective experiences.
In our view, a cognitive-mediational conceptualization of emotion (Lazarus, 1991 ) is a useful framework for defining emotion regulation. From this perspective, emotion regulation is conceptualized as the process by which individuals modulate any of the subcomponents of the emotion system, including elements that might contribute to emotion, such as an individual's personal appraisal of the situation, and the responses tendencies generated by emotions (i.e., feelings, expressive behaviors, and physiological reactions) (Schulz & Lazarus, 2012) . Emotion regulatory processes involve three main mechanisms: input regulation (i.e., strategies used to alter factors that shape the generation of emotion, such as attentional deployment), reappraisal 5 (i.e., strategies used to change the meaning of an encounter, such as viewing a situation in a more positive light), and output regulation (i.e., strategies used to regulate emotional responses including expression of emotion) (Gross, 2001; Schulz & Lazarus, 2012) . Emotion regulatory processes can be planful, deliberate, and rational, but they can also unfold out of consciousness.
Coping is a set of cognitive and behavioral efforts that is initiated by an appraisal of a particular situation as having personal meaning. Coping efforts are guided by an individual's objectives in that situation; these objectives are likely to include a desire to regulation emotions in a particular manner (Schulz & Lazarus, 2012) . In this perspective, strategies of emotion regulation can be understood to part of the larger coping efforts used to respond to the stress associated with the diagnosis and experience of breast cancer.
The present study aims to systematically review the measures currently used to assess strategies to regulate emotions within the context of breast cancer. The intent is to summarize the main characteristics of these measures and evaluate their psychometric properties in order to facilitate researchers' choices about which scales to use to assess these strategies in both clinical settings and in research studies. Thus, the main research questions that guide this review are: (1) What instruments have been used to assess strategies used by breast cancer patients to regulate emotions? (2) What is the evidence for the reliability and validity of these instruments? (3) What are the main findings regarding the consequences of using specific strategies to regulate emotions for breast cancer patients? To our knowledge this is the first systematic review addressing this question.
Method
This systematic review was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines (Moher, Liberati, Tetzlaff, Altman, The PRISMA Group, 2009 ).
Eligibility criteria
Full-text research articles published in English that included at least one instrument to measure dimensions of emotion regulation or emotional expression in women with breast cancer were eligible. Exclusion criteria included: (1) non-English-language articles; (2) articles not measuring aspects of emotion regulation or emotional expression; (3) articles that were not specific to breast cancer (e.g., articles were excluded if they included other types of cancer or other diseases or participants without medically diagnosed breast cancer, such as studies of women with genetic risk to develop breast cancer); (4) literature reviews, books, unpublished articles and doctoral theses, commentaries, abstracts of conferences and congresses, case-reports, and qualitative studies; (5) articles using exclusively general personality questionnaires; and (6) validation studies.
Search strategy
Database searches were conducted from inception to September 2014 in Academic Search Complete, CINAHL plus, ERIC, MedicLatina, MEDLINE, PsycARTICLES, PsycCRITIQUES, Psychology and Behavioral Sciences Collection, and PsycINFO. Searches in these databases were supplemented by additional manual searching in Google. The key search terms used were: breast cancer OR mastectomy AND emotion* regulation, OR emotion* expression OR emotion* control OR emotion* self-efficacy OR emotion* suppression OR affect regulation. After duplicates were removed, titles and abstracts were assessed for eligibility independently by two researchers. Disagreements were discussed and resolved by consensus.
Results
The results are presented in three sections: (1) a description of the included studies, (2) a description of the instruments used to measure emotion regulation strategies, and (3) a description of main findings presented by the included studies regarding dimensions of emotion regulation.
Description of the included studies
A total of 679 articles were identified: 201 from PsycInfo, 188 from MEDLINE Search Complete, 135 from Academic Search Complete, 95 from CINAHL Plus, 41 from Psychology and Behavioural Sciences Collection, 12 from PsycArticles, 2 from ERIC, 1 from MedicLatina, and 6 from manual searching. After duplicate studies were removed, 345 studies remained and the abstracts were carefully screened and evaluated. From these, 277 were excluded (28 were non-English articles; 120 did not measure emotion regulation or emotion expression; 29 included other types of cancer or diseases; 93 were literature reviews, qualitative studies or abstracts of conferences or congresses;4 measured personality traits, and 3 were exclusively validation studies) (see flow chart in Figure 1) .
A final 68 studies were retrieved for full text screening. From these 9 were excluded because, after further review, they were found to not include a measure to assess emotion regulation or emotional expression. A total of 59 studies were, therefore, included in this review. The majority of studies were longitudinal in nature (n = 24; 41%) followed by randomized controlled trials or (quasi) experimental designs (n = 16; 27%). The remaining were crosssectional (n = 19; 32%). Studies were most commonly conducted in the USA (n = 23; 39%), but there was a wide variety of other locales (Japan, Spain, Netherlands, New Zealand, China, Israel, France, Canada, Italy, Finland, Greece, Norway, United Kingdom, Portugal, Belgium, and Denmark). Data were gathered from 8,181 participants (sample sizes ranged from 22 to 847 participants) with a mean age of 64.62 years. All studies included women with BC stage I-IV (some studies also included healthy controls or women with benign tumors). A detailed description of all included studies (characteristics and main results) is shown in Supplementary material available online.
Description of the instruments used to measure emotion regulation strategies
Among the reviewed studies, we found 16 different instruments used for measuring coping strategies that primarily involved the regulation of emotions in the context of breast cancer. Table 1 summarizes information about the instruments' characteristics. The most frequently reported measure was the Courtauld Emotional Control Scale (Watson & Greer, 1983 ; n = 32 studies; 56%) followed by the Emotional Approach Coping Scale ; n = 7 studies; 12%), the Toronto Alexithymia Scale (Bagby, Parker, & Taylor, 1994 ; n = 6 studies; 11%), the Weinberg Adjustment Inventory -Short Form (Weinberger, 1990 ; n = 6 studies; 11%), the Stanford Emotional Self-efficacy Scale -Cancer (Giese-Davis et al., 2004 ; n = 5 studies; 9%), the Cancer Behavior Inventory (Merluzzi, 2001 ; n = 3 studies; 5%), the Control of Feeling Scale (Benjamin & Friedrich, 1991 ; n = 3 studies; 5%); the Rationality/Emotional Defensiveness (Spielberger, 1988 ; n = 3 studies; 5%), the Ambivalence over Emotional Expression Questionnaire (King & Emmons, 1990 ; n = 2 studies; 4%), the Cognitive Emotion Regulation Questionnaire (Garnefski, Kraaij, & Spinhoven, 2002 ; n = 2 studies; 4%), and the Emotional Expressiveness Questionnaire (King & Emmons, 1990 ; n = 2 studies; 4%). A number of relevant scales were used only once: the Berkeley Expressivity Questionnaire (Gross & John, 1995) , the COPE (Carver, Scheier, & Weintraub, 1989) ; the Emotion Self-Disclosure Scale (Snell, Miller, & Beck, 1988) , the Marlowe Crowne Social Desirability Scale (Crowne & Marlowe, 1964) , and the Ways of Coping Questionnairemodified (Reynolds et al., 2000) . All measures were self-report. Details about each of the 16 measures follow.
(Insert table 1 about here)
The Courtauld Emotional Control Scale (CECS)
The CECS was developed by Watson and Greer (1983) as a questionnaire to measure emotional control, a tendency to control or suppress the expression of negative emotions when communicating to others. It evaluates how individuals control their feelings of anger, anxiety, and depressed mood in daily experiences. It comprises 21 items that can be organized into 3 subscales: anger control (7 items; e.g., "When I feel angry I keep quiet"), anxiety control (7 items; e.g., "When I feel afraid I let others see how I feel"), and depressed mood control (7 items; e.g., "When I feel unhappy I refuse to do anything about it") scored on a Likert-type scale from 1 (almost never) to 4 (almost always). A majority of studies have used the CECS as an overall scale to measure "control of emotions" or "suppression of emotions". It has been the most common scale used to evaluate emotion control in the context of breast cancer and presented good internal consistency with α's ranging from .83 to .95 (Ando et al., 2011; Andreu et al., 2012; Cameron et al., 2007; Classen et al., 1996; Giese-Davis et al., 2002 , 2006b Iwamistu et al., 2003 Iwamistu et al., , 2005a Iwamistu et al., , 2005b Schlatter et al., 2010) and reliability with 3-4 month testretest reliability = .95 (Schlatter et al., 2010) .
The Emotional Approach Coping Scale (EACS)
The EACS uses a subset of the items from the Brief-COPE (Carver, 1997) to assess coping through emotional approach, which involves acknowledging, understanding, and expressing emotions (Austenfeld & Stanton, 2004) . It comprises 2 subscales: emotional expression defined as active verbal and/or nonverbal efforts to communicate or represent one's emotional experience (4 items; e.g., "I allow myself to express my emotions") and emotional processing defined as an active efforts to acknowledge, explore meanings, and come to an understanding of one's emotions (4 items; e.g., "I acknowledge my emotions").
The EACS is scored on a Likert-type scale from 1 (usually do not do this at all) to 4 (usually do this a lot). Studies reported good internal consistency for the emotional expression subscale (α's ranged from .78 to .91) (Batenburg et al., 2014; Cohen et al., 2011; Manne et al., 2004 Manne et al., , 2007 Puig et al., 2006; Stanton et al., , 2012 and good test-retest reliability (r = .72) (Puig et al., 2006) . The emotional processing subscale was found to have low internal consistency in two studies (α = .32 and .63; Manne et al., 2004; Stanton et al., 2012, respectively) but the remaining studies reported good internal consistency (α's range from .69 to .91) (Batenburg et al., 2014; Cohen et al., 2011; Manne et al., 2007; Puig et al., 2006; and good test-retest reliability when reported (r = .73) (Puig et al., 2006) .
The Toronto Alexithymia Scale (TAS)
The TAS was developed by Bagby, Parker, and Taylor (1994) to measure alexithymia or difficulty in experiencing, identifying, describing and verbally communicating one's feelings to others. It is composed of 20 items with 3 subscales: difficulty identifying feelings (7 items; e.g. "I am often confused about what emotion I am feeling"), difficulty describing feelings (5 items; e.g., "I am able to describe my feelings easily"), and externally oriented thinking that is conceptualized as a tendency to focus one's attention externally as a way to avoid feelings (8 items; e.g., "I prefer to analyze problems rather than just describe them"). Each item is scored on a 5-point Likert-type scale from 1 (completely disagree) to 5 (completely agree). Two studies reported data regarding internal consistency (α's range between .81 and .95; Jensen-Johansen et al., 2013; Servaes et al., 1999) .
The Weinberger Adjustment Inventory -Short Form (WAI-SF)
The WAI-SF was developed by Weinberger (1990) and is composed of 3 subscales (distress -12 items; restraint -12 items; and repressive-defensiveness -11 items). The studies included here have used the repressive-defensiveness subscale to tap emotional repression. Repression is conceptualized as an unconscious tendency to avoid remembering or bringing into awareness disturbing feelings or unpleasant cognitions . The WAI measures repression with eleven items (e.g., "I have done things that were not right and felt sorry about it later), scored on a Likert-type scale from 1 (false) to 5 (true).
Four studies reported data regarding internal consistency (α's range from .69 to .73) Servaes et al., 1999; Tamagawa et al., 2013) . A previous study found good one-year test-retest reliability (r = .75 ) (Giese-Davis & Spiegel, 2001 ).
The Stanford Emotional Self-Efficacy Scale -Cancer (SESES)
The SESES was developed by Giese-Davis et al. (2004) to measure emotion regulation and expression in patients coping with cancer. It is based on emotion regulation theories that emphasize the importance disclosing and communicating emotions, regulating emotions to be able to focus on the present, and tolerance of affect associated with death and dying concerns (Giese-Davis et al., 2004) . This measure is composed of 15 items that comprise 3 subscales: communicating emotions in relationships (5 items; e.g., "Let my friends know when I am angry because of something they did"), focusing on the present moment (5 items; e.g., "Focus my full attention on one thing at a time"), and confronting death and dying issues (5 items; e.g., "Directly consider the thought that I might die."). This scale measures perceived self-efficacy around one's ability to manage emotions in these domains; Giese-Davis et al., 2004) . It is scored on a 100-point Likert-type scale ranging from 0 (not at all confident) to 100 (completely confident) in increments of 10.
The initial evaluation of psychometric proprieties was performed with a breast cancer sample (Giese-Davis et al., 2004) . The authors found good internal consistency (total score α = .89; communicating emotions α = .82; focusing on present α = .79; and confronting death α = .80) and good three month test-retest reliabilities for the total score and for two of the three 13 subscales (total score r = .69; communicating emotions r = .71; and confronting death r = .67).
The exception is for the subscale focusing on present, which had lower test-retest reliability (r = .57). Concurrent validity was assessed by comparing the SESES with the CECS. Results showed a medium to large negative correlation between suppression of emotions (CECS) and emotional self-efficacy (SESES-C). Evidence for predictive validity and generalizability were also presented (for more details see Giese-Davis et al., 2004) . The subsequent studies using this 
The Cancer Behavior Inventory (CBI)
The CBI was developed by Merluzzi and Martinez Sanchez (1997) to assess self-efficacy for coping with cancer. It is composed of 51 items divided into 6 subscales (affective regulation; maintenance of activity and independence; seeking and understanding medical information; stress management; coping with treatment-related side-effects; accepting cancer/maintaining positive attitude; seeking support). The affective regulation subscale aims to assess one's sense of confidence in effectively regulating and expressing negative feelings (5 items; e.g., "Expressing feelings about cancer"; "Sharing my worries or concerns with others"). Items are scored on a 9-point scale ranging from 1 (not all confident) to 9 (totally confident). One study reported internal consistency for the total scale (α = .95) (Collie et al., 2007) . 14 7. The Control of Feeling Scale (CFS)
The CFS (also referred to as the Acceptance of Emotions Scale) was adapted by Wheis et al.
(2000) based on the Structural Analysis of Social Behavior Intrex developed by Benjamin and Friedrich (1991) . It is a 13-item scale used to measure how individuals view their emotions, how they relate to them (including whether they accept them as is or try to change them), and how they control them (e.g., "I try very hard to make my feelings as ideal as possible"). All items are scored on a 100-point Likert-type scale ranging from 0 (never/ not at all) to 100 (always/ perfectly) in increments of 10. The instrument presented good internal consistency (α = .92) (Politi, Enright, & Wheis, 2007) and test-retest reliability (r = .58) (Wheis, Enright, & Simmens, 2008) . No other studies were found using this instrument even in contexts other than breast cancer.
The Rationality/Emotional Defensiveness (R/ED)
The R/ED was developed by Spielberger (1988) to measure defensive attempts to minimize emotional experience or expression. It is a 12-item scale with each item scored on a 4-point Likert-type scale ranging from 0 (almost never) to 4 (almost always). The R/ED has 2 subscales: emotional defensiveness (or anti-emotionality), defined as a tendency to use logic and reason to avoid or minimize upsetting emotions in interpersonal contexts (6 items; e.g., "I try to understand other people even if I do not like them), and rationality, defined as a tendency to use logic and reason as a general approach to cope with the environment (6 items; e.g., "I try to do what is sensible and logical" (Fernandez-Ballesteros, Zamarrón, Ruiz, Sebastian, & Spielberger, 1997; Letho et al., 2006) .
For the one study that reported data regarding internal consistency, α's ranged from .81 to .88, and test-retest reliability was good, r = .81 (Fernandez-Ballesteros et al., 1998) .
The Ambivalence over Emotional Expression Questionnaire (AEEQ)
The AEEQ was developed by King and Emmons (1990) to assess ambivalence or worries about expressing emotions. It is a one-dimensional scale and is composed of 28 items (e.g., "I want to express my emotions honestly but I am afraid that it may cause me embarrassment or hurt").
Items are scored on a 5-point Likert-type scale ranging from 0 (never) to 4 (always). Two studies used the AEEQ and showed good internal consistency (α = .87 and .93) (Algoe et al., 2011; Servaes et al., 1999) .
The Cognitive Emotion Regulation Questionnaire (CERQ)
The CERQ is a multidimensional questionnaire developed by Garnefski, Kraaij, and Spinhoven (2002) that measures cognitive components of emotion regulation, specifically, the cognitive coping strategies that individuals use to deal with negative or stressful events. The CERQ consists of 36 items organized into 9 subscales: self-blame (4 items; e.g., "I feel that I am the one who is responsible for what has happened"), acceptance (4 items; e.g., "I think that I must learn to live with it"), rumination (4 items; e.g., "I dwell upon the feelings the situation has evoked in me"), positive refocusing (4 items; e.g., "I think of something nice instead of what has happened"), refocus on planning (4 items; e.g., "I think about how I can best cope with the situation"), positive reappraisal (4 items; e.g., "I think that I can become a stronger person as a result of what has happened"), putting into perspective (4 items; e.g., "I think that it all could have been much worse"), catastrophizing (4 items; e.g., "I keep thinking about how terrible it is what I have experienced"), and other-blame (4 items; e.g., "I feel that others are responsible for what has happened"). All items are scored on a 5-point Likert-type scale ranging from 1 (almost never) to 5 (almost always). Two studies reported internal consistency information (in Hamana 
The Emotional Expressiveness Questionnaire (EEQ)
The EEQ is a measure developed by King and Emmons (1990) that aims to measure overall emotional expressiveness or the tendency to express emotional responses in ways that can be observable by others. It is a one-dimensional scale composed of 16 items (e.g., "When I am angry people around me usually know") scored on a 7-point Likert-type scale. One study reported information regarding internal consistency (α = .80) (Servaes et al., 1999) .
The Berkeley Expressivity Questionnaire (BEQ)
The Berkeley Expressivity Questionnaire was developed by Gross and John (1995) to measure emotional expressivity. It is a 16-item questionnaire with 3 subscales: negative expressivity, which taps the tendency to express negative emotions (6 items; e.g., "Whenever I feel negative emotions, people can easily see exactly what I am feeling"), positive expressivity, which taps the tendency to express positive emotions (4 items; e.g., "When I feel happy, my feelings show"), and impulse strength, which taps the intensity of how one experiences feeling states (6 items; e.g., "I experience my emotions very strongly"). One study found good internal consistency (α > .94) and two-three month test-retest reliability (r = .86) (Stanton et al., 2012) . Similarly strong reliabilities have been reported for the BEQ in studies with populations other than breast cancer patients (e.g., Gross & John, 1995) .
The COPE Inventory
The COPE short-form was developed by Carver, Scheier, and Weintraub (1989) to measure coping strategies. It is widely used and is composed of 60 items, divided into two major categories: emotion-focused strategies (including emotional expression(4 items), seeking social support (4 items), positive reinterpretation (4 items), acceptance (4 items), turning to religion (4 items), denial (4 items), behavioral disengagement (4 items), distraction (4 items), drug and alcohol abuse (4 items), and humor (4 items)) and problem-focused strategies (including active coping (4 items), planning (4 items), suppression of competing activities (4 items), restraint (4 items), and information seeking (4 items)). Participants respond to items on a 4-point Likert-type scale ranging from 1 (I haven't been doing this at all) to 4 (I've been doing this a lot). Internal consistency for ten subscales ranged between .54 and .98 with two falling below .60 (the following 5 subscales were not included: restraint, suppression of competing activities, religion, drug and alcohol use, and behavioral disengagement) (Roussi et al., 2007) . The COPE Inventory is a widely used measure outside the context of breast cancer. A search of the PsychInfo database using the term COPE inventory showed that it appears in 233 publications.
14. The Emotion Self-Disclosure Scale (ESDS)
The ESDS was developed by Snell, Miller, and Belk (1988) to measure people's tendency to be open and to express their emotions to a friend, a romantic partner, or a physician/ therapist. It has 18 40 items that can be broken down into 8 subscales (each one composed of 5 items) that assess the extent to which a person has discussed specific types of feelings and emotions with others: feelings of depression, happiness, jealousy, anxiety, anger, calmness, apathy, fear, and pain. Servaes et al. (1999) used a short-version of the ESDS with 17 items. Internal consistency for the overall scale was good (α = .93).
The Marlowe Crowne Social Desirability Scale (MCSDS)
The MCSDS was developed by Crowne and Marlowe (1964) to measure social desirability independent of psychopathology. It has also been used as a measure of emotional constraint that is intended to capture a defensive tendency to avoid affect that a person believes is not socially desirable (Wheis et al., 2000) . It is a one-dimensional scale comprised of 33 items (e.g., "I almost never feel the urge to tell someone off") scored on a true-false format. It has good internal consistency (KR20 = .80) and adequate one month test-retest reliability (r = .88) (Wheis et al., 2000) .
The Ways of Coping Questionnaire -Modified (WCQ-M)
The WCQ-M, developed by Reynolds et al. (2000) is a modified version of the widely used Ways of Coping Questionnaire from Folkman and Lazarus (1980) . It is used to measure coping strategies adopted by individuals when confronting a stressful situation. It is composed of 28 items that break down into 7 subscales: expressing emotion (3 items; e.g., "Talk to someone about how you are feeling"), suppressing emotions (3 items: e.g., "Try to keep feelings to yourself"), wishful thinking (5 items; e.g., "Wish situation would go away or be over with"), problem-solving (4 items; e.g., "Learn as much as you can in order to better understand"), positive reappraisal (5 items; e.g., "Remind yourself how much worse things could be"), avoidance (5 items; e.g., "Go on as if everything will be okay"), and escapism (3 items; e.g., "Try to get away from it by doing relaxing things"). Items are scored on a 4-point Likert-type scale ranging from 0 (does not apply or not used) to 3 (used a great deal). Information regarding psychometric proprieties of this modified version was not available in the study that employed this scale (Reynolds et al., 2002) . The WCQ is widely used in other contexts. A search of the PsychInfo database using the term Ways of Coping Questionnaire showed that it appears in 491 publications.
Some studies used more than one instrument, so some information regarding intercorrelations between instruments is available. Graves et al. (2005) analyzed the correlation between four of the instruments included here (the CECS, the TAS, the EEQ, and the R/ED).
They found that the TAS was positively correlated with the CECS (r = .46, p < .01) and negatively correlated with the EEQ (r = -.41, p < .01). The moderate to large magnitude of the correlations suggests that the instruments are tapping similar but not overlapping constructs. Stanton et al. (2012) found a correlation between the BEQ and the EACS. The BEQ was positively correlated with both emotional processing (r = .21, p < .05) and emotional expression (r = .44, p < .001).
As would be expected, Giese-Davis et al. (2002 found significant negative correlations between the CECS and the SESES-C (r = -.55, p < .01, r = -.43, p < .001). In the 2002 study neither the CECS nor the SESES-C were correlated with the WAI.
Description of the main findings from the included studies regarding dimensions of emotion regulation
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Measures tapping emotional suppression or dampening (as measured by the CECS) were associated in some studies with more distress, more mood disturbances, more stress related symptoms, and more physical symptoms. However, other studies found that emotion suppression or dampening (as measured by the CECS) was not significantly related to psychological distress, autonomic physiology, or survival (Ando et al., 2011; Giese-Davis et al., 2008; Goodwin et al., 2004; Nakatani et al., 2014; Watson et al., 1999) .Emotional dampening, as measured by the WCQ, was associated with longer survival times (Andreu et al., 2012; Classen et al., 1996; Reynolds et al., 2000; Schlatter et al., 2010; Tamagawa et al., 2013) .
Measures tapping greater emotional expression were related to fewer depressive symptoms, greater life satisfaction, more posttraumatic growth, better perceived health, less psychological distress, fewer medical visits (when measured by the EACS). However, one study found that emotional expression (measured by the EACS) was not significantly related to depression, well-being, and breast cancer concerns (Batenburg et al., 2014) . Emotional expression was also associated with more survival (when measured with the WCQ and the R/ED), and more distress (when measured with the COPE) (Batenburg et al., 2014; Cohen et al., 2011; Letho et al., 2006; Manne et al., 2004; Reynolds et al., 2000; Roussi et al., 2007; Stanton et al., , 2012 .
Emotional self-efficacy (that is confidence about emotion modulation and emotional expression) measured by the SESES-C was related to fewer mood disturbances, problems in medical interaction, and traumatic stress symptoms (Han et al., 2005; Koopman et al., 2002; Palesh et al., 2006) . Self-efficacy of affect regulation, when measured by the CBI, was negatively related to difficulties in communicating with medical staff (Collie et al., 2005) . More restraint and repression, as measured by the WAI, was related to higher blood pressure and more 21 problematic cortisol functioning . Acceptance, positive refocusing, and positive reappraisal, as measured by the CERQ, were associated with fewer depressive symptoms (Wang et al., 2014) . Stronger efforts to control feelings (measured by the CFS) were associated with more psychological distress and higher mortality. Emotional constraint (measured by the MCSDS) was also related to higher mortality (Wheis et al., 2000) .
More detailed information regarding significant and non-significant results obtained with each scale can be seen in Table 2. (Insert Table 2 about here)
With regard to the effects of psychosocial interventions on emotion regulation and emotional expression strategies for breast cancer patients, six studies that delivered a psychosocial intervention designed to target emotion processes (e.g., expression of emotions, mindfulness interventions, relaxation and guided imagery techniques) found that emotional control/ suppression (measured with the CECS) decreased after psychological intervention (Cameron et al., 2007; Chan et al., 2006; Giese-Davis et al., 2002; Henderson et al., 2012 Henderson et al., , 2013 Walker et al., 1999) . One study using the WAI to tap emotion restraint found that supportiveexpressive group therapy increased restraint of hostility among women with breast cancer . In one study, emotional expression and emotional processing (measured with the EACS) amplified the positive effects of a couple's group intervention on distress and well-being (Manne et al., 2007) and in another study alexithymia (measured with the TAS) moderated the effect of an expressive writing intervention on cancer-related distress (i.e., , 2002, 2006) . One concern that is important to highlight is that changes in strategies used to regulate emotions were not tested as possible mediators of intervention efficacy in the already limited pool of studies evaluating the efficacy of psychological intervention in this population. Future intervention studies should examine this mediational role of emotion regulatory processes.
Discussion
It is important for both clinicians and researchers to be able to choose effective instruments to measure strategies breast cancer patients use to regulate their emotions given the impact these strategies have on adaptation. In this systematic review we aimed to identify instruments that have been used to measure emotion regulatory strategies in women with breast cancer, to analyze the psychometric proprieties of these instruments, and to analyze the main results from studies using these instruments regarding emotion regulatory strategies. To our knowledge this is the first systematic review about this topic.
We found that 16 different instruments have been used to measure the strategies used by breast cancer patients to regulate their emotions. The majority of the instruments were originally designed as general measures of coping and intended to assess individual differences in the use 23 of specific coping strategies to regulate emotions. Overall, the most commonly used instruments tend to emphasize one's ability to control or dampen emotions (the CECS; the WAI; the R/ED; the WCQ; the CFS; and the MCSDS); one's ability to express emotions (the EACS; the SESES-C; the EEQ; the CBI; the WCQ; the COPE; the ESDS; the AEEQ; and the BEQ); and one's ability to identify emotions (the EACS and the TAS). There are differences across these studies on what aspects of emotion regulation or strategies are most important to tap. However, it is clear that the majority of studies have focused on strategies used to dampen the expression of negative emotions (i.e., suppression or inhibition of emotional expression). In fact, the CECS, which measures a general tendency to control or suppress the expression of negative emotions, has been the most commonly used scale in the context of research on breast cancer, followed by the EACS, which measures a tendency to engage (approach) the emotions elicited in stressful situations by acknowledging, understanding, and expressing them. In sum, the most commonly used instruments focus on tendencies to regulate the expression of negative emotions and include a wide range of specific strategies including conscious suppression and more automatic or defensive strategies (e.g., rationality, repression) that help individuals distance themselves from negative affect.
The focus on dampening emotional expression and on strategies that distance individuals from discomforting emotions is consistent with research on emotion regulatory processes outside of breast cancer that suggests there are costs to these strategies (e.g. Gross & John, 2003; Waldinger & Schulz, 2010) . Some emotion researchers have found it helpful to characterize regulatory strategies in terms of whether they promote engagement with or distancing from negative affective experiences (Waldinger & Schulz, 2010) . Accumulating evidence provides support for the idea that emotional avoidance has adaptational costs and is also a risk factor for a 24 range of psychological disorders (Aldao, 2013; Werner & Gross, 2009; Waldinger & Schulz, 2010) . However, even this view has been challenged by researchers who argue that the adaptive consequences of regulatory strategies depend greatly on circumstances and on the specific person employing them (e.g., Bonanno & Burton, 2013; Consedine, Magai, & Bonanno, 2002; Schulz & Lazarus, 2012) .
In line with this, beliefs and goals that guide one's attempts to regulate emotions should be assessed in order to understand why a particular regulatory focus or strategy is being invoked and why it might be effective for one person or in one situation but not another. This is something that the majority of instruments employed to study emotion regulation or coping fail to do (Schulz & Lazarus, 2012) . Regulatory efforts to dampen emotion may be motivated by a number of personal goals. We think it is important to examine the motives that guide emotion regulation for women with breast cancer. For example, are the adaptational consequences similar if one is motivated to distance oneself from emotions to help getting through a difficult medical procedure rather than to avoid upsetting an important provider of social support? Also, another aspect that is understudied is the importance of examining emotion regulation in the context of close relationships, namely studying how intimate connections may shape emotion regulation efforts (and also how emotion regulation influences close relationships). In fact, none of the studies identified in this systematic review analyzed the role relational variables play in shaping the strategies used to regulate emotions when coping with breast cancer, and this is an aspect that needs further consideration.
Not surprisingly, the different instruments found in studies of breast cancer tapped different aspects of emotion regulation. We think it is important to consider multiple components of the emotion system when emotion regulatory processes are under study in order to better 25 capture the complexity of emotion processes and of the adaptational consequences of specific regulatory efforts. In addition to being focused on altering the three "output" channels of emotion (i.e., experiential, physiological, and behavioral), regulatory efforts can focus on choosing or modifying one's situation, altering one's attentional focus or changing one's understanding of the situation (Schulz & Lazarus, 2012) . Within each of these foci, there are a number of strategies that can be invoked to regulate emotions. From this perspective, it becomes clear why it might be difficult to find one instrument or construct that captures the "key" regulatory strategies. For this reason, theory and research questions should always inform the specific choice of instruments selected. Instruments that measure multiple regulatory strategies (e.g., broad coping indices) can be employed in more exploratory work.
Analyses focused on the structure or reliability of the measures in the identified studies included assessments of internal consistency (reported as a Cronbach alpha or as a KuderRichardson (KR20) coefficient alpha), test-retest reliability, and, in one study, the internal factor structure using confirmatory factor analysis (Wang et al., 2014) . Of the 55 studies included, 27 (51%) did not report any information regarding the reliability or factor structure of the instruments used. For the remaining studies, the majority of measures showed adequate internal consistency (α > .70) and test-retest reliability (r > .60) (Hunsley & Mash, 2008) . Only four studies reported poor internal consistency (α's between .32 and .59); the poor reliabilities were found for instruments used to tap emotional processing, cognitive emotion regulation strategies, coping strategies, and restraint Hamana-Ray et al., 2012; Manne et al., 2004; Roussi et al., 2007) . We recommend further validation studies for these specific instruments in order to review and improve their psychometric proprieties.
It is important to highlight that there are measures commonly used to assess emotion regulation and emotional expression in the larger field of psychology and medicine that have not been used in oncology studies. For example, we did not find any studies using the Emotion Regulation Questionnaire (Gross & John, 2003) that is widely used to measure tendencies to use reappraisal and suppression and has been in existence for more than a decade. Another widely used measure, the Difficulties in Emotion Regulation Scale (Gratz & Roemer, 2004) , which focuses on several regulatory styles found to be associated with psychopathology and poor adaptation, was also not found in our search of studies of breast cancer. We recommend that researchers integrate these well-vetted measures into studies of women with breast cancer.
Finally, and as expected, there was a connection between the ways in which women with breast cancer regulate their emotions and different aspects of psychological adaptation to breast cancer. The fact that these associations were found across measures that overlapped in their intended constructs but differed in their specific content provides some reassurance about the validity of these measures. We cannot, however, conclude that these measures are assessing common constructs. We think that future studies should strive to evaluate the degree of redundancy among measures of emotion regulation-related constructs in order to evaluate if each instrument is assessing a distinct dimension or if a set of instruments can be integrated into a common measure (or measurement model) because they are assessing similar dimensions. Little information regarding intercorrelations among existing instruments is available, however the limited data available suggest that different instruments are assessing different constructs.
It is critical to recognize that the results obtained in the identified studies are influenced by a number of factors beyond the instruments used. Such factors include sample size, type of psychological intervention delivered, and the reliability and validity of other measures employed in the studies. Also, it is important to keep in mind that this systematic review was limited to English-language and peer-reviewed studies. This means that there is a risk of reporting bias and relevant studies may not have been included in this review.
Research and clinical implications
This systematic review can inform researchers' choices about scales to use to measure key aspects of individual differences in the ways in which women with breast cancer might regulate and express emotions. Also, the review can contribute to more accurate measurement of the constructs under examination. More accurate measurement may help reduce inconsistencies in findings across studies and more reliably detect changes in emotion processing over time, something that is particularly important in randomized controlled trials. There is still much to learn about the nature of the relationship between emotion regulatory strategies and adaptation to breast cancer, but the findings of this study point to strategies that clinicians may want to focus on and consider in their work with women with breast cancer. Because there are a large number of strategies that can be invoked to regulate emotions and context is likely to influence the utility of these strategies it is important to keep studying and exploring which strategies can help women cope better with the challenges associated with breast cancer. The results of this systematic review provide some guidance for researchers and clinicians to pick instruments with stronger psychometric proprieties and those which have been linked with specific psychosocial dimensions.
This systematic review also points to directions that may help improve the assessment of strategies used to regulate emotions, including the inclusion of the goals or motivations that are driving regulatory efforts. Screening of emotion regulatory and emotional expression styles is an 28 important priority given the role that these strategies play in breast cancer adaptation. The use of such screening measures could help facilitate the identification of women who are in greatest need and can benefit from psychological interventions that focus on emotional elements.
